CSIRO research, with collaborators and industry, is revolutionising the treatment of influenza and other viral diseases with drugs of pinpoint precision. Using computers, they are designing drugs that 'lock' onto critical unchanging sections of the viruses and stop them causing infection - even if they mutate.